Projektdetaljer
| Status | Igangværende |
|---|---|
| Effektiv start/slut dato | 01/08/2025 → 31/07/2026 |
Novo Nordisk Fonden - Innovator Grants - Pioneer - Targeted delivery of KRAS Splice-Switching antisense oligonucleotides (SSOs) to treat metastatic colon cancer
- Andresen, Brage Storstein (Projektdeltager)
Projekter: Projekt › Private fonde